Publication date: December 2026 Source: Journal of Shoulder and Elbow Arthroplasty, Volume 10, Issue 4 Author(s): Amelia Hummel, Alexander J. Acuña, Alexander Hornung, Ryan Lew, William Harkin, Grant E. Garrigues, Gregory Nicholson
Evaluating the safety of glucagon-like peptide-1 agonist use in non-diabetic overweight patients undergoing shoulder arthroplasty. // Journal of Shoulder and Elbow Arthroplasty. – URL: https://www.sciencedirect.com/science/article/pii/S2471549226000882?dgcid=rss_sd_all
Evaluating the safety of glucagon-like peptide-1 agonist use in non-diabetic overweight patients undergoing shoulder arthroplasty. Journal of Shoulder and Elbow Arthroplasty. https://www.sciencedirect.com/science/article/pii/S2471549226000882?dgcid=rss_sd_all
“Evaluating the safety of glucagon-like peptide-1 agonist use in non-diabetic overweight patients undergoing shoulder arthroplasty.” Journal of Shoulder and Elbow Arthroplasty.
@article{article55407,
title = {Evaluating the safety of glucagon-like peptide-1 agonist use in non-diabetic overweight patients undergoing shoulder arthroplasty},
journal = {Journal of Shoulder and Elbow Arthroplasty},
url = {https://www.sciencedirect.com/science/article/pii/S2471549226000882?dgcid=rss_sd_all}
}